These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 6355849

  • 1. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.
    Santos GW, Tutschka PJ, Brookmeyer R, Saral R, Beschorner WE, Bias WB, Braine HG, Burns WH, Elfenbein GJ, Kaizer H.
    N Engl J Med; 1983 Dec 01; 309(22):1347-53. PubMed ID: 6355849
    [Abstract] [Full Text] [Related]

  • 2. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F, Copelan E, Crilley P, Bolwell B, Avalos B, Klein J, Territo M, Gajewski J.
    Bone Marrow Transplant; 1996 May 01; 17(5):685-9. PubMed ID: 8733682
    [Abstract] [Full Text] [Related]

  • 3. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide.
    Yeager AM, Kaizer H, Santos GW, Saral R, Colvin OM, Stuart RK, Braine HG, Burke PJ, Ambinder RF, Burns WH.
    N Engl J Med; 1986 Jul 17; 315(3):141-7. PubMed ID: 3523241
    [Abstract] [Full Text] [Related]

  • 4. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.
    Haematologica; 2002 Jan 17; 87(1):52-8. PubMed ID: 11801465
    [Abstract] [Full Text] [Related]

  • 5. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
    Zander AR, Berger C, Kröger N, Stockshläder M, Krüger W, Horstmann M, Grimm J, Zeller W, Kabisch H, Erttmann R, Schönrock P, Kuse R, Braumann D, Illiger HJ, Fiedler W, de Witt M, Hossfeld KD, Weh HJ.
    Clin Cancer Res; 1997 Dec 17; 3(12 Pt 2):2671-5. PubMed ID: 10068272
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia.
    Brochstein JA, Kernan NA, Groshen S, Cirrincione C, Shank B, Emanuel D, Laver J, O'Reilly RJ.
    N Engl J Med; 1987 Dec 24; 317(26):1618-24. PubMed ID: 3317056
    [Abstract] [Full Text] [Related]

  • 7. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
    Kröger N, Zabelina T, Sonnenberg S, Krüger W, Renges H, Stute N, Finkenstein F, Mayer U, Holstein K, Fiedler W, Colberg H, Sonnen R, Kuse R, Braumann D, Metzner B, del Valle F, Erttmann R, Kabisch H, Zander AR.
    Bone Marrow Transplant; 2000 Oct 24; 26(7):711-6. PubMed ID: 11042650
    [Abstract] [Full Text] [Related]

  • 8. Successful allogeneic bone marrow transplantation for three children with acute nonlymphocytic leukemia.
    Ohira M, Takayama J, Hanada M.
    Jpn J Clin Oncol; 1984 Dec 24; 14 Suppl 1():487-93. PubMed ID: 6097709
    [Abstract] [Full Text] [Related]

  • 9. Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia.
    Blume KG, Beutler E, Bross KJ, Chillar RK, Ellington OB, Fahey JL, Farbstein MJ, Forman SJ, Schmidt GM, Scott EP, Spruce WE, Turner MA, Wolf JL.
    N Engl J Med; 1980 May 08; 302(19):1041-6. PubMed ID: 6245359
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF.
    Bone Marrow Transplant; 1997 Jul 08; 20(1):5-10. PubMed ID: 9232249
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
    Mehta J, Powles R, Treleaven J, Horton C, Tait D, Meller S, Pinkerton CR, Middleton G, Eisen T, Singhal S.
    Bone Marrow Transplant; 1996 Oct 08; 18(4):741-6. PubMed ID: 8899189
    [Abstract] [Full Text] [Related]

  • 12. [High-dose busulfan, VP-16 and ACNU therapy with stem cell transplantation for the treatment of children with acute leukemia].
    Ikuta K, Fujioka K, Sumita H, Takahashi H, Sekiguchi H, Kai S, Kajigaya Y, Funabiki T, Sakai H, Matsuyama S.
    Rinsho Ketsueki; 1993 May 08; 34(5):636-42. PubMed ID: 8100284
    [Abstract] [Full Text] [Related]

  • 13. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
    Long GD, Amylon MD, Stockerl-Goldstein KE, Negrin RS, Chao NJ, Hu WW, Nademanee AP, Snyder DS, Hoppe RT, Vora N, Wong R, Niland J, Reichardt VL, Forman SJ, Blume KG.
    Biol Blood Marrow Transplant; 1997 Dec 08; 3(6):324-30. PubMed ID: 9502300
    [Abstract] [Full Text] [Related]

  • 14. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
    Duerst RE, Horan JT, Liesveld JL, Abboud CN, Zwetsch LM, Senf ES, Constine LS, Raubertas RF, Passarell JA, DiPersio JF.
    Bone Marrow Transplant; 2000 Mar 08; 25(5):489-94. PubMed ID: 10713624
    [Abstract] [Full Text] [Related]

  • 15. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide.
    Galimberti M, Polchi P, Lucarelli G, Angelucci E, Baronciani D, Giardini C, Gaziev D, Erer B, Ripalti M, Rapa S.
    Bone Marrow Transplant; 1994 Feb 08; 13(2):197-201. PubMed ID: 8205089
    [Abstract] [Full Text] [Related]

  • 16. Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation.
    Geller RB, Myers S, Devine S, Larson RA, Williams SF, Park CL, O'Toole K, Chandler C, Topper RL.
    Bone Marrow Transplant; 1992 Jan 08; 9(1):41-7. PubMed ID: 1543948
    [Abstract] [Full Text] [Related]

  • 17. Bone marrow transplantation following busulfan and cyclophosphamide for acute myelogenous leukemia.
    Crilley P, Topolsky D, Bulova S, Bigler R, Brodsky I.
    Bone Marrow Transplant; 1990 Mar 08; 5(3):187-91. PubMed ID: 2331539
    [Abstract] [Full Text] [Related]

  • 18. Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation.
    Emminger W, Emminger-Schmidmeier W, Haas OA, Urban C, Ambros P, Peters C, Mann G, Fink FM, Ferstl G, Höcker P.
    Bone Marrow Transplant; 1992 May 08; 9(5):313-8. PubMed ID: 1617314
    [Abstract] [Full Text] [Related]

  • 19. Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission.
    Inoue T, Ikeda H, Yamazaki H, Tang JT, Song C, Teshima T, Murayama S, Ohtani M, Shibata H, Masaoka T.
    Strahlenther Onkol; 1993 Apr 08; 169(4):250-5. PubMed ID: 8488461
    [Abstract] [Full Text] [Related]

  • 20. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
    Zhang XH, Huang XJ, Liu KY, Xu LP, Liu DH, Chen H, Chen YH, Wang JZ, Han W, Lu DP.
    Chin Med J (Engl); 2007 Mar 20; 120(6):463-8. PubMed ID: 17439737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.